Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)

China flag China · Delayed Price · Currency is CNY
5.19
-0.02 (-0.38%)
Jul 3, 2026, 3:04 PM CST
Market Cap3.03B -8.6%
Revenue (ttm)747.80M -10.0%
Net Income54.99M -30.5%
EPS0.09 -28.4%
Shares Out 583.05M
PE Ratio59.14
Forward PEn/a
Dividend0.01 (0.23%)
Ex-Dividend DateMay 27, 2026
Volume12,508,638
Open5.40
Previous Close5.21
Day's Range5.10 - 5.40
52-Week Range4.59 - 6.82
Beta0.15
Analystsn/a
Price Targetn/a
Earnings DateAug 24, 2026

About SHE:300239

Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen in the People’s Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private label collagen and unflavored collagen jars. The company also provides organic fertilizers, water soluble fertilizers, and compound microbial fertilizers; and industrial grade calcium... [Read more]

Sector Healthcare
Founded 1960
Employees 1,424
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300239
Full Company Profile

Financial Performance

In 2025, SHE:300239's revenue was 745.31 million, a decrease of -15.78% compared to the previous year's 884.93 million. Earnings were 54.34 million, a decrease of -36.80%.

Financial Statements